Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma
1 other identifier
interventional
1,000
1 country
1
Brief Summary
Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 3, 2025
CompletedFirst Submitted
Initial submission to the registry
July 23, 2025
CompletedFirst Posted
Study publicly available on registry
September 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
September 30, 2025
July 1, 2025
1.6 years
July 23, 2025
September 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Adherence to inhaled treatment measured by Five Steps Assessment (FSA).
Assessment of adherence to inhaled treatment measured by patients' behavior towards inhaled treatment and a number of mistakes in inhalation technique.
Assessment of adherence to inhaled treatment within 12 months.
Adherence to inhaled treatment measured by the Medication Adherence Report Scale (MARS).
Assessment of adherence to inhaled treatment measured by patients' behavior towards inhaled treatment and a number of mistakes in inhalation technique.
Assessment of adherence to inhaled treatment within 12 months.
Critical knowledge measured by our own questionnaire in healthcare professionals caring for patients with COPD and bronchial asthma.
Assessment of Critical knowledge by questions on correct usage of particular inhalation systems related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma.
Critical knowledge related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma within 12 months
Critical skills related to inhalation techniques measured by FSA in healthcare professionals caring for patients with COPD and bronchial asthma.
Assessment of critical skills measured by a number of mistakes in inhalation technique in particular inhalation systems related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma.
Critical skills related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma within 12 months.
Secondary Outcomes (1)
Assessment of clinical (e.g. CAT in patients with COPD) and laboratory (e.g. white blood cell count) biomarkers potentially indicating the stability of COPD and bronchial asthma in a subgroup of patients.
Assessment of clinical and laboratory biomarkers potentially indicating the stability of COPD and bronchial asthma within 12 months.
Study Arms (1)
All project participants
OTHEREducation of inhalation technique
Interventions
Eligibility Criteria
You may qualify if:
- signed informed consent,
- age ≥ 18 years,
- previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,
- ability to cooperate,
- at least 8 weeks without exacerbation,
- use of a particular inhaler for at least 3 months.
You may not qualify if:
- pre-terminal/terminal stage of any disease,
- uncooperative patient,
- significant limitation of mobility or cognitive functions.
- HEALTHCARE PROFESSIONALS
- signed informed consent,
- completed education in medicine, pharmacy, or nursing,
- more than one year of working experience,
- care for patients taking inhaled therapy for BA/COPD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Charles University, Czech Republiclead
- Ministry of Health, Czech Republiccollaborator
- University Hospital Hradec Kralovecollaborator
- University of Hradec Hralovecollaborator
Study Sites (1)
University Hospital Hradec Králové
Hradec Králové, 500 05, Czechia
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2025
First Posted
September 19, 2025
Study Start
June 3, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2028
Last Updated
September 30, 2025
Record last verified: 2025-07